Every AI newsletter, investors ask questions on the investor interaction platform: Hello, Secretary! How many of the company’s antiaging agents are proprietary? Does the insufficient capacity of the current general-purpose antioxidant affect the sales of the company’s preferred products?
Rianlon Corporation(300596) (300596. SZ) said on the investor interaction platform on January 22 that the company has applied for patent protection in product field, preparation process and engineering device; The production capacity of general antioxidants has an impact on u-pack sales.
